Skip to main content

Table 2 Follow-up of infants treated by cART for at least 3 months (ANRS-PEDIACAM Study, 2008–2013, Cameroon)

From: Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

 

N = 167

M3 visit

M12 visit

M24 visit

 

% (n)

% (n)

% (n)

Dead

0.0 (0)

5.3 (9)a

2.4 (4)b

Visit not performed

20.4 (34)

23.4 (39)

29.1 (64)

Visit performed

79.6 (133)

71.3 (119)

48.5 (81)

 Viral load (cp/mL)

   

  < 400

35.3 (59)

52.7 (88)

34.1 (57)

 [400-1000]

15.6 (26)

4.8 (8)

3.6 (6)

  ≥ 1000

36.5 (61)

18.0 (30)

9.6 (16)

 not measured

12.6 (18)

24.5 (41)

59.3 (88)

Accompanied by:

   

 Mother

79.0 (105)

73.1 (87)

71.6 (58)

Grandmother

8.3 (11)

8.4 (10)

8.6 (7)

 Aunt

5.9 (8)

5.9 (7)

5.0 (4)

 Other

6.8 (9)

12.6 (15)

14.8 (12)

Questionnaire completed

N = 151

N = 126

N = 126

Questionnaire completed and viral load measured

N = 144

N = 125

N = 67

  1. cART combined antiretroviral therapy, N total number, Mx delay from ART initiation to the current visit, e.g. «M3» means «3 months after cART initiation», % percentage; n number of patients in the cell
  2. a<12 months
  3. b12 to 24 months